REPL ALERT: Securities Fraud Class Action Launched Against Replimune Group, Inc. - October 5, 2026 Deadline
Levi & Korsinsky announced a securities class action filed against Replimune Group covering investors who purchased REPL securities between October 20, 2025 and April 10, 2026, with a lead plaintiff deadline of October 5, 2026. The complaint alleges FDA study-design concerns were not addressed in the BLA and that the company submitted data from an early unplanned analysis of RP1-104 that included only 40 of a planned 400 patients.
Key figures
- Class period end
- April 10, 2026
- Class period start
- October 20, 2025
- Planned enrollment
- 400
- Patients in analysis
- 40
- Lead plaintiff deadline
- October 5, 2026
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.